Management of oxidative stress and other pathologies in Alzheimer's disease
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder, characterized by
the formation, aggregation and accumulation of amyloid beta, perturbed metal (copper, iron …
the formation, aggregation and accumulation of amyloid beta, perturbed metal (copper, iron …
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
Q Li, H Yang, Y Chen, H Sun - European journal of medicinal chemistry, 2017 - Elsevier
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disorders with
notable factor of dysfunction in cholinergic system. Low ACh level can be observed in the …
notable factor of dysfunction in cholinergic system. Low ACh level can be observed in the …
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998–2018)
Alzheimer's disease (AD) is a genetically complex, progressive and irreversible
neurodegenerative disorder of the brain which involves multiple associated etiological …
neurodegenerative disorder of the brain which involves multiple associated etiological …
Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases
VS Gontijo, FPD Viegas, CJC Ortiz… - Current …, 2020 - ingentaconnect.com
Neurodegenerative Diseases (NDs) are progressive multifactorial neurological pathologies
related to neuronal impairment and functional loss from different brain regions. Currently, no …
related to neuronal impairment and functional loss from different brain regions. Currently, no …
Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease
A Hiremathad, RS Keri, AR Esteves… - European journal of …, 2018 - Elsevier
Alzheimer's disease (AD) is a severe age-dependent neurodegenerative disorder affecting
millions of people, with no cure so far. The current treatments only achieve some temporary …
millions of people, with no cure so far. The current treatments only achieve some temporary …
In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease
In this research, we have implemented two-dimensional quantitative structure-activity
relationship (2D-QSAR) modeling using two different datasets, namely, acetylcholinesterase …
relationship (2D-QSAR) modeling using two different datasets, namely, acetylcholinesterase …
New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents
JM Roldan-Pena, D Alejandre-Ramos, O Lopez… - European journal of …, 2017 - Elsevier
We have designed a series of tacrine-based homo-and heterodimers that incorporate an
antioxidant tether (selenoureido, chalcogenide) as new dual compounds: for the treatment of …
antioxidant tether (selenoureido, chalcogenide) as new dual compounds: for the treatment of …
The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease
V Hepnarova, J Korabecny, L Matouskova… - European Journal of …, 2018 - Elsevier
Novel tacrine-benzyl quinolone carboxylic acid (tacrine-BQCA) hybrids were designed
based on multi-target directed ligands (MTLDs) paradigm, synthesized and evaluated in …
based on multi-target directed ligands (MTLDs) paradigm, synthesized and evaluated in …
Tacrine-based hybrids: past, present, and future
A Bubley, A Erofeev, P Gorelkin… - International Journal of …, 2023 - mdpi.com
Alzheimer's disease (AD) is a neurodegenerative disorder which is characterized by β-
amyloid (Aβ) aggregation, τ-hyperphosphorylation, and loss of cholinergic neurons. The …
amyloid (Aβ) aggregation, τ-hyperphosphorylation, and loss of cholinergic neurons. The …
Novel tacrine–benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's Disease
G Fancellu, K Chand, D Tomás… - Journal of enzyme …, 2020 - Taylor & Francis
Pursuing the widespread interest on multi-target drugs to combat Alzheimer´ s disease (AD),
a new series of hybrids was designed and developed based on the repositioning of the well …
a new series of hybrids was designed and developed based on the repositioning of the well …